Sensorineural Hearing Loss: Clinical Trials

1 trial for Sensorineural Hearing Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Sensorineural Hearing Loss: new trials by email Literature Review of Sensorineural Hearing Loss trials Research Report on Sensorineural Hearing Loss

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
Valganciclovir, Simple Syrup - Cmv Congenital, CMV
Phase 2TerminatedAlbert Park102018-08-312026-08-27

Narrower conditions

Cytomegalovirus Infections (1)  ·  Hearing Loss, Sensorineural (1)

Broader conditions

DNA Virus Infections (1)  ·  Ear Diseases (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)  ·  Virus Diseases (1)

Interventions

Valganciclovir (1)

Sponsors

Albert Park (1)

Countries

United States (1)

Top investigators

Albert Park, MD (1)

Results publications

PMID 38415855

NIH funding

U01DC014706 (1)